Effect of riluzole on cytosolic Ca2+ increase in human osteosarcoma cells

Pharmacology

Volumn 66, Issue 3, 2002, Pages 120-127

  Jan, Chung Ren ^a   Lu, Yih Chau ^a   Jiann, Bang Ping ^a   Chang, Hong Tai ^a   Huang, Jong Khing ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Ca2+; Ca2+ stores; Fura 2; MG63; Osteosarcoma cells; Riluzole

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; ADENOSINE TRIPHOSPHATASE; BRADYKININ; CALCIUM ION; FURA 2; HISTAMINE; LANTHANUM; NIFEDIPINE; PHOSPHOLIPASE C; RILUZOLE; THAPSIGARGIN; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; NEUROPROTECTION; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

CALCIUM; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOSARCOMA; RILUZOLE; TUMOR CELLS, CULTURED;

EID: 0036420587     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063798     Document Type: Article

References (47)

1. Clark W, Kendall MJ: Therapeutic advances: Riluzole for the treatment of motor neurone disease. J Clin Pharmacol Ther 1996;21:373-376.
2. Bryson HM, Fulton B, Benfield P: Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs 1996;52: 549-563.
3. Doble A: The pharmacology and mechanism of action of riluzole. Neurology 1996;47(suppl 4):S233-S241.
4. Wagner ML, Landis BE: Riluzole: A new agent for amyotrophic lateral sclerosis. Ann Pharmacother 1997;31:738-744.
5. + channels TREK-1 and TRAAK. Mol Pharmacol 2000;57:906-912.
6. Wu SN, Li HF: Characterization of riluzole-induced stimulation of large-conductance calcium-activated potassium channels in rat pituitary GH3 cells. J Investig Med 1999;47:484-495.
7. Bausch AR, Roy G: Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells (U-138MG). Glia 1996;18: 73-77.
8. Benoit E, Escande D: Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflügers Arch 1991;419:603-609.
9. Song JH, Huang CS, Nagata K, Yeh JZ, Narahashi T: Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistantsodium channels. J Pharmacol Exp Ther 1997; 282:707-714.
10. Siniscalchi A, Zona C, Sancesario G, D'Angelo E, Zeng YC, Mercuri NB, Bernardi G: Neuro-protective effects of riluzole: An electrophysiological and histological analysis in an in vitro model of ischemia. Synapse 1999;32:147-152.
11. Hebert T, Drapeau P, Pradier L, Dunn RJ: Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 1994;45:1055-1060.
12. Wahl F, Stutzmann JM: Neuroprotective effects of riluzole in neurotrauma models: A review. Acta Neurochir Suppl 1999;73:103-110.
13. Zona C, Siniscalchi A, Mercuri NB, Bernardi G: Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 1998;85:931-938.
14. Kretschmer BD, Kratzer U, Schmidt WJ: Riluzole, a glutamate release inhibitor, and motor behavior. Naunyn Schmiedebergs Arch Pharmacol 1998;358:181-190.
15. McIntosh TK, Smith DH, Voddi M, Perri BR, Stutzmann JM: Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J Neurotrauma 1996;13:767-780.
16. Malgouris C, Daniel M, Doble A: Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci Lett 1994; 177:95-99.
17. Lang-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M: Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole. J Vasc Surg 2000;32:179-189.
18. Mu X, Azbill RD, Springer JE: Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res 2000; 870:66-72.
19. Hammer NA, Lilleso J, Pedersen JL, Kehlet H: Effect of riluzole on acute pain and hyperalgesia in humans. Br J Anaesth 1999;82:718-722.
20. Boireau A, Meunier M, Imperato A: Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole. J Pharm Pharmacol 1998;50:1293-1297.
21. Yokoo H, Shiraishi S, Kobayashi H, Yanagita T, Yamamoto R, Wada A: Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol 1998;357:526-531.
22. Keita H, Lepouse C, Henzel D, Desmonts JM, Mantz J: Riluzole blocks dopamine release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum. Anesthesiology 1997;87:1164-1171.
23. Azbill RD, Mu X, Springer JE: Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 2000;871: 175-180.
24. Berridge MJ: Inositol trisphosphate and calcium signaling. Nature 1993;361:315-325.
25. Berridge MJ: Elementary and global aspects of calcium signalling. J Physiol (Lond) 1997;499: 291-306.
26. Bootman MD, Berridge MJ, Lipp P: Cooking with calcium: The recipes for composing global signals from elementary events. Cell 1993;91: 367-373.
27. Budd SL: Mechanisms of neuronal damage in brain hypoxia/ischemia: Focus on the role of mitochondrial calcium accumulation. Pharmacol Ther 1998;80:203-229.
28. Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T: Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997;282:1280-1290.
29. Hubert JP, Burgevin MC, Terro F, Hugon J, Doble A: Effects of depolarizing stimuli on calcium homeostasis in cultured rat motoneurones. Br J Pharmacol 1998;125:1421-1428.
30. 2+ levels in IMR32 neuroblastoma cells. Arch Toxicol 2001;75:214-220.
31. 2+ mobilization induced by W-7 in MG63 human osteosarcoma cells. Pharmacol Res 2000;42:323-327.
32. Chen YC, Chen SJ, Chang HT, Huang JK, Wang JL, Tseng LL, Chang HJ, Su W, Law YP, Chen WC, Jan CR: Mechanisms of diethylstilbestrol-induced calcium movement in MG63 human osteosarcoma cells. Toxicol Lett 2001; 122:245-253.
33. i increases in human osteoblast-like cells. Chin J Physiol. 2001;44:67-72.
34. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM: Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 1999;25:631-637.
35. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
36. 2+ mobilization in Madin-Darby canine kidney (MDCK) cells. J Pharmacol Exp Ther 2000; 294:96-102.
37. 2+-ATPase. Proc Natl Acad Sci USA 1990;87:2466-2470.
38. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK: The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 1991; 266:23856-23862.
39. Romanello M, Pani B, Bicego M, D'Andrea P: Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 2001;289:1275-1281.
40. Romanello M, Padoan M, Franco L, Veronesi V, Moro L, D'Andrea P: Extracellular NAD(+) induces calcium signaling and apoptosis in human osteoblastic cells. Biochem Biophys Res Commun 2001;285:1226-1231.
41. Koh JY, Kim DK, Hwang JY, Kim YH, Seo JH: Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons. J Neurochem 1999;72:716-723.
42. 2+ entry in MG63 human osteosarcoma cells. Biochem Pharmacol 2001;61:1537-1541.
43. 2+ mobilization in MG63 human osteosarcoma cells. Horm Res 2001;55:265-270.
44. Romanello M, D'Andrea P: Dual mechanism of intercellular communication in HOBIT osteoblastic cells: A role for gap-junctional hemi-channels. J Bone Miner Res 2001;16:1465-1476.
45. Yamamura J, Takada Y, Goto M, Kumegawa M, Aoe S: Bovine milk kininogen fragment 1.2 promotes the proliferation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 2000;269:628-632.
46. Lesclous P, Guez D, Saffar JL: Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H(2) receptor antagonist cimetidine. Bone 2002;30:131-136.
47. Le Liboux A, Lefebvre P, Le Roux Y, Truffinet P, Aubeneau M, Kirkesseli S, Montay G: Single- and multiple-dose pharmacokinetics of riluzole in white subjects. J Clin Pharmacol 1997;37:820-827.